Pharaoh Neuro Secures $20 Million Series A and Appoints CEO and CMO to Advance Neurapheresis™ Platform

Pharaoh Neuro, Inc., a medical device company developing innovative solutions for neurocritical care, today announced the closing of an oversubscribed $20 million Series A financing and the appointments of Amaza Reitmeier as Chief Executive Officer and Nandan Lad, M.D., Ph.D., as Chief Medical Officer. The Series A was led by Arboretum Ventures, with participation from Hatteras Venture Partners, the Laerdal Million Lives Fund and IAG Capital Partners.